NR3C2 (nuclear receptor subfamily, 3; group C member, 2) is a known tumor suppressor, and its expression was found to be reduced in colon carcinoma, clear-cell renal cell carcinoma, and pancreatic cancer (18–20). Here, NR3C2 is linked to neoplasm.